CompletedNot Applicable

COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk / World Health Organization (WHO)

France204 participantsStarted 2023-09-22

Plain-language summary

This study is a multicenter, international, non interventional, retrospective study about SARS-CoV-2 and Multisystem Inflammatory Syndrome (MIS-C) reinfection risk in children.

Who can participate

Age range

1 Day – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: group 1: cases * Patients with MIS-C (following SARS CoV-2 infection) * Hospitalised between the 01 sep 2021 and 30 apr 2022 * Under 18 years of age * Not vaccinated for SARS-CoV-2 group 2: controls * Patients not hospitalised, treated by outpatient care * With documented SARS-CoV-2 infection between the 01 sep 2021 and 30 apr 2022 * Matched with a case on age (+/- 6 months), gender and country * Not vaccinated for SARS-CoV-2 Exclusion Criteria: \- Refusal to participate by patient relative or legal representative

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

proportion of MIS-C cases occurred after first SARS-CoV-2 infection

Timeframe: 8 months

proportion of MIS-C cases occurred after SARS-CoV-2 reinfection

Timeframe: 8 months

Proportion of SARS-CoV-2 reinfection after first SARS-CoV-2 infection

Timeframe: 8 months

Trial details

NCT IDNCT06255860

SponsorAssociation Clinique Thérapeutique Infantile du val de Marne

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-01

View on ClinicalTrials.gov More Sars-CoV-2 Infection trials

Who can participate

Age range

1 Day – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.